CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 9 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-23 | KIRITSY CHRISTOPHER P Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-06-23 | Kiener Peter A Director | Grant or award · Stock Options (Right to buy) | +40,000 | 40,000 | ||
| 2020-06-23 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-06-23 | Barbier Ann Director | Grant or award · Stock Options (Right to buy) | +40,000 | 40,000 | ||
| 2020-02-27 | Bures Thomas Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2020-02-27 | Kaufmann Hitto SVP, Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2020-02-27 | Yoder Stephen S. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +420,000 | 420,000 | ||
| 2020-01-25 | Sherman Matthew L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-25 | Said Maya R. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-25 | Kiener Peter A Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-25 | Barbier Ann Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-25 | KIRITSY CHRISTOPHER P Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-25 | BIZZARI JEAN-PIERRE Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +5,431 | $2.11 | $11K | 5,431 |
| 2020-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-25 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2019-10-25 | Richman Michael Director | Grant or award · Stock Options (right to buy) | +5,165 | $2.12 | $11K | 5,165 |
| 2019-09-06 | BVF PARTNERS L P/IL 10% owner | Sale | −23,152 | $4.50 | $104K | 2,385,055 |
| 2019-09-06 | BVF PARTNERS L P/IL 10% owner | Sale | −25,720 | $4.50 | $116K | 2,233,074 |
| 2019-09-06 | BVF PARTNERS L P/IL 10% owner | Sale | −1,128 | $4.50 | $5K | 314,139 |
Page 13 of 21 · 412 trades